Information for patients on the HIV-1 seroconverter study of the Robert Koch Institute. Object of the study: Investigation of the course of HIV infection in patients with a known date of infection. Analysis of epidemiological, virological, immunological and clinical parameters with regard to the course of the disease. Valid from 01.06.2024